Mark Identification
MAGNITUDE CLINICAL TRIAL
Serial Number
97830256
Filing Date
Mar 9, 2023
Trademark by
Classification Information
Organizing and recruiting patients for clinical trials for the treatment of transthyretin (ATTR) amyloidosis using in vivo gene editing technology
Advertising and BusinessScientific research in the nature of conducting clinical trials for the treatment of transthyretin (ATTR) amyloidosis using in vivo gene editing technology
Computer and ScientificMedical treatment of transthyretin (ATTR) amyloidosis using in vivo gene editing technology
Medical, Beauty & Agricultural